申请人:GlaxoSmithKline LLC
公开号:US20140357643A1
公开(公告)日:2014-12-04
The present invention relates to compounds characterized by having a structure according to the following Formula I:
, or a pharmaceutically acceptable salt thereof. Compounds of the present invention are useful for the treatment or prevention of HIV.
本发明涉及具有以下I式结构的化合物,或其药学上可接受的盐。本发明化合物对于治疗或预防HIV具有用途。